Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 51.61B | 54.08B | 55.89B | 50.95B | 39.76B | 36.01B |
Gross Profit | 10.34B | 11.44B | 11.92B | 9.61B | 7.31B | 5.48B |
EBITDA | 4.58B | 5.39B | 6.83B | 5.70B | 2.85B | 1.31B |
Net Income | 2.40B | 2.90B | 3.77B | 2.67B | 2.35B | -143.00M |
Balance Sheet | ||||||
Total Assets | 71.43B | 73.85B | 71.21B | 63.97B | 54.80B | 49.99B |
Cash, Cash Equivalents and Short-Term Investments | 9.89B | 8.76B | 8.84B | 7.09B | 7.35B | 7.50B |
Total Debt | 26.84B | 26.38B | 22.71B | 18.83B | 15.09B | 19.41B |
Total Liabilities | 50.34B | 51.00B | 48.99B | 43.36B | 38.38B | 41.28B |
Stockholders Equity | 20.49B | 22.20B | 21.61B | 6.67B | 2.71B | 9.70B |
Cash Flow | ||||||
Free Cash Flow | 1.36B | 138.00M | -920.00M | -1.42B | 1.34B | 3.37B |
Operating Cash Flow | 3.09B | 1.55B | 386.00M | -523.00M | 2.10B | 4.17B |
Investing Cash Flow | -2.11B | -2.55B | -2.08B | -4.17B | 4.26B | -2.35B |
Financing Cash Flow | -1.42B | 403.00M | 2.93B | 3.33B | -875.00M | -1.14B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
71 Outperform | ¥258.06B | 14.45 | 8.48% | 2.82% | 6.33% | 12.20% | |
64 Neutral | €31.42B | 12.92 | 11.21% | 4.86% | -6.83% | -32.20% | |
― | €48.75B | 8.22 | 6.28% | ― | ― | ― | |
― | €10.64B | 2.05 | 3.63% | ― | ― | ||
― | €45.98B | 5.42 | 5.01% | ― | ― | ― | |
― | €45.98B | 5.57 | 5.01% | ― | ― | ― | |
73 Outperform | €14.84B | 6.81 | 12.80% | 5.78% | -2.98% | -14.55% |